[Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].
Vuitton
D A
DA
Service de Médecine Interne, CHU Jean-Minjoz, Besançon.
Chossegros
P
P
Bresson-Hadni
S
S
Delfraissy
J F
JF
Kirn
A
A
Marcellin
P
P
Pol
S
S
Saint-Paul
M C
MC
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D003699:Hepatitis D / Q000150:complications* / Q000188:drug therapy; D006521:Hepatitis, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D016898:Interferon-alpha; D015215:Zidovudine
Foie, voies biliaires et infection par le virus de l'immunodéficience humaine. 1re partie: Foie, VIH et virus des hépatites B, C et D.